...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Have a great Sunday, especially those of you like me that are celebrating Orthodox Easter ... As well as those of you who are also like me and mourning another Maple Leafs Game 7 exit ... Ugggh!

Sincerely,

George et al

Message: Re: Does anyone have a link to the patent application?

Further to this thread, DND just remember that Pfizer will have to deal with RVX should they want to pursue this patent app to a therapeutic. This is not like RVX having the patent on Apabetalone + rosuvastatin where rosuvastatin is no longer patent protected.  Apabetalone obviously as we know is patent protected.  I think it is great to see so many RVX/Zenith compounds listed in the patent application as it certainly would seem to support the RVX/Zenith contention that they are world leaders in this area of science. 

Share
New Message
Please login to post a reply